≡

Multiplex Assay Kit for Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay)

ANX5; ENX2; PP4; PAP-I; CBP-I; Anchorin CII; Calphobindin I; Endonexin II; Lipocortin V; Placental anticoagulant protein 4; Thromboplastin inhibitor; Vascular anticoagulant-alpha

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-99 95
EDTA plasma(n=5) 89-104 101
heparin plasma(n=5) 88-97 93
sodium citrate plasma(n=5) 81-93 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 96-105% 79-105% 98-105% 85-95%
EDTA plasma(n=5) 88-98% 80-101% 90-97% 89-101%
heparin plasma(n=5) 87-102% 91-98% 80-89% 80-103%
sodium citrate plasma(n=5) 79-96% 80-98% 86-105% 89-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:ANXA5) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Molecular Biology Markers of apoptotic dysfunctions in schizophrenia Pubmed: 24466757
Neuroscience and Behavioral Physiology Involvement of Anomalous Apoptosis in Impairments to Synaptic Plasticity in Post-Traumatic Stress Disorder Springer: Source
Inflammation and Cell Signaling Collectins, C3 complement protein, annexin V and C-reactive protein in acute ischemic stroke: interrelation and implication to upregulated apoptosis and inflammation Smartscitech: Source
Lung Annexin A5 Protein as a Potential Biomarker for the Diagnosis of Asthma Pubmed: 30182154
Catalog No. Related products for research use of Rhesus monkey (Simian) Organism species Applications (RESEARCH USE ONLY!)
RPA259Si01 Recombinant Annexin V (ANXA5) Positive Control; Immunogen; SDS-PAGE; WB.
PAA259Si01 Polyclonal Antibody to Annexin V (ANXA5) WB; IHC; ICC; IP.
MAA259Si21 Monoclonal Antibody to Annexin V (ANXA5) WB; IHC; ICC; IP.
SEA259Si ELISA Kit for Annexin V (ANXA5) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA259Si Multiplex Assay Kit for Annexin V (ANXA5) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.